Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company
July 26, 2024 01:00 ET
|
Ackermans & van Haaren
Dear shareholder, Dear Madam, Dear Sir, please find attached our press release. Best regards Ackermans & van Haaren
Attachment
...
Signify reports second quarter sales of EUR 1.5 billion, operational profitability of 7.9% and a free cash flow of EUR 51 million
July 26, 2024 01:00 ET
|
Signify
Press Release July 26, 2024 Signify reports second quarter sales of EUR 1.5 billion, operational profitability of 7.9% and a free cash flow of EUR 51 million ...
Bekaert: 2024 Half Year Results
July 26, 2024 01:00 ET
|
Bekaert
Strategic progress and financial resilience delivers improved profit margins Sales at € 2.1 billion • EBITu of € 204 million (margin 9.9%) • EPSu of € 3.04 • Free Cash Flow of € 43 million •...
SPIE - Press release - 2024 Half-Year results
July 26, 2024 00:54 ET
|
SPIE SA
Cergy, July 26th, 2024 Strong half-year results reflecting the strengths of SPIE’s business model and quality of execution Revenue: €4,704.5 million, up +14.4% vs. H1 2023 (of which +8.3% from...
Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Vicor Corporation (VICR)
July 26, 2024 00:45 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Vicor Corporation (VICR) Misled Investors Regarding its AI Platform
Shareholder Rights Law Firm Robbins LLP Reminds Stockholders of the Opportunity to Lead the MongoDB, Inc. (MDB) Class Action
July 26, 2024 00:41 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that MongoDB, Inc. (MDB) Misled Investors Regarding its Business Prospects
Kaerus Bioscience kondigt de start aan van Fase 1 klinische studie voor zijn nieuwe BK-kanaalmodulator KER-0193, die wordt ontwikkeld voor het fragiele-X-syndroom
July 26, 2024 00:29 ET
|
Kaerus Bioscience
LONDEN, July 26, 2024 (GLOBE NEWSWIRE) -- Kaerus Bioscience Ltd. (www.kaerusbio.com), een biotechnologiebedrijf dat zich richt op de ontwikkeling van therapeutica voor zeldzame genetische syndromen...
BOAR'S HEAD PROVISIONS CO. RECALLS READY-TO-EAT LIVERWURST AND OTHER DELI MEAT PRODUCTS DUE TO POSSIBLE LISTERIA CONTAMINATION
July 26, 2024 00:13 ET
|
USDA Food Safety and Inspection Service
Washington, DC, July 26, 2024 (GLOBE NEWSWIRE) -- Recall Release CLASS I RECALLHEALTH RISK: HIGH Congressional and...
CORRECTING and REPLACING – SPS Commerce Reports Second Quarter 2024 Financial Results
July 25, 2024 23:46 ET
|
SPS Commerce, Inc.
MINNEAPOLIS, July 25, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline on July 25, 2024 by SPS Commerce, Inc. (NASDAQ: SPSC), please note that the range of Non-GAAP income per...
NIP Group Inc. Announces Pricing of $20.25 Million Initial Public Offering
July 25, 2024 22:30 ET
|
NIP GROUP INC.
STOCKHOLM, July 26, 2024 (GLOBE NEWSWIRE) -- NIP Group Inc. (the “Company” or “NIP”), a leading esports organization with the most expansive global footprint by virtue of its operations across Asia,...
- July 30, 2024 08:03 ET Lofty Introduces Property Management System, LoftyWorks
- July 30, 2024 08:01 ET Global Narcolepsy Drugs Market Report 2024-2032: Therapeutic Types, Disease Types, End Users, Countries, and Company Analysis Featuring Jazz Pharmaceuticals, Ligand Pharmaceuticals, Novartis, and More